Dalbavancin is a lipoglycopeptide with an exceptionally long half-life that allows simplified administration, which may be of value in long-term treatment of bone and joint infections, such as prosthe
This is a supplemental data, Figshare1, in our paper "A simple strategy for a low-cost, portable plasma drug monitoring with sustainable boron-doped diamond chip".
